mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
0.003 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |